Effects of Retinoids on the Mucosal Immune System

类维生素A对粘膜免疫系统的影响

基本信息

  • 批准号:
    7757206
  • 负责人:
  • 金额:
    $ 27.88万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2009
  • 资助国家:
    美国
  • 起止时间:
    2009-07-01 至 2014-06-30
  • 项目状态:
    已结题

项目摘要

instmctions): The simultaneous constraint of highly efficient protective immunity together with the prerequisite for tolerance towards innocuous antigens Imposes a significant challenge for the intesfinal mucosal immune system. Several mechanisms operating in different types of DCs and/or T cells have been identified that control immune tolerance and protective immunity. TGF-|3 in particular is a crucial regulator capable of inducing FoxpS+Tregs, but paradoxically, in the presence of pro-inflammatory cytokines, promoting the conversion to Thi7 effector cells. This contrasting deviation puts TGF-(3 as a principal controller of pro- and anti-inflammatory immune responses. Recently we demonstrated that retinoic acid and other retinoids function as key regulators of the TGF-P-dependent immune deviation, capable of inhibiting the induction of proinflammatory Thi7 cells but promoting the TGF-P-dependent differentiation of anti-inflammatory FoxpS+lTregs. We further showed that in the absence of innate danger signals, retinoids can be absorbed and released by the DCs to the T cells they prime. The released retinoids then directly target differential gene expression within the T cell to promote anti-inflammatory and tolerant immunity. In the presence of danger signals sensed by the DCs, retinoids no longer suppress pro-inflammatory differentiation of primed T cells, suggesting that under innate stimulation conditions, retinoid-mediated suppressive effects on T cells are abolished and/or that retinoid signaling in the presence of innate stimuli can turn towards the DCs and promote their antigen presenting function and protective immune responses. The study proposed here, aims at elucidating retinoid-mediated mechanisms that operate in T cells or DCs and that control the balance between tolerance and protective immunity. The indicated collaborative approaches with Units 1,2 and 3 of this PPG, will allow us to extend this study and evaluate the potential cross talk between the retinoid pathways and other cellular mechanisms involved in immune regulation, as well as the role of retinoid-mediated control in directing immune responses towards specific pathogens, using various infecfious animal models. RELEVANCE (See instructions): The knowledge gained from this study will expand our understanding of regulation of pro- and anti¿ inflammatory immune responses, in particular involving mechanisms employed by the mucosal immune system to control local and systemic immunity. The study has also great potential for the identiflcation of new drug targets that may improve exisfing therapies or may lead to the development of novel medical intervention opportunities to prevent and/or treat intestinal inflammatory diseases.
说明): 高效保护性免疫的同时约束及其前提条件 对无害抗原的耐受性对最终的粘膜免疫构成了重大挑战。 系统。已确定在不同类型的DC和/或T细胞中工作的几种机制 控制免疫耐受和保护性免疫。尤其是转化生长因子-3是一种关键的调节因子,能够 诱导FoxpS+Tregs,但矛盾的是,在促炎细胞因子的存在下,促进 转化为Thi7效应细胞。这种相反的偏差使转化生长因子-(3)成为PRO-AND的主要控制器 抗炎免疫反应。最近我们证明了维甲酸和其他类维甲酸 作为转化生长因子-β依赖的免疫偏离的关键调节因子,能够抑制诱导 促炎症Thi7细胞可促进转化生长因子-β依赖分化的抗炎作用 FoxpS+lTregs。我们进一步证明,在没有先天危险信号的情况下,类维甲酸可以被吸收 并由DC释放到它们激活的T细胞。然后,释放的维甲酸直接针对差异 T细胞内的基因表达促进抗炎和耐受免疫。在……面前 树突状细胞感知的危险信号,维甲酸不再抑制Primed的促炎分化 T细胞,提示在天然刺激条件下,维甲酸对T细胞的抑制作用 细胞被取消和/或在存在先天刺激的情况下类维甲酸信号可以转向DC 并促进其抗原提呈功能和保护性免疫反应。这项研究建议 在这里,旨在阐明维甲酸介导的机制,它在T细胞或DC中工作,并控制 在耐受性和保护性免疫之间取得平衡。与单元1、2的指定协作方法 和3个PPG,将使我们能够扩展这项研究,并评估 类维甲酸途径和其他参与免疫调节的细胞机制,以及 类维A酸介导的针对特定病原体的免疫反应的控制,使用不同的 感染性动物模型。 相关性(请参阅说明): 从这项研究中获得的知识将扩大我们对正反两方面调控的理解 炎性免疫反应,特别是涉及粘膜免疫所使用的机制 控制局部和全身免疫的系统。这项研究也有很大的潜力来识别 可能改进现有疗法或可能导致新医学发展的新药物靶点 预防和/或治疗肠道炎症性疾病的干预机会。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

HILDE MC CHEROUTRE其他文献

HILDE MC CHEROUTRE的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('HILDE MC CHEROUTRE', 18)}}的其他基金

The Role of Cytoplasmic and Nuclear THEMIS in Immature and Mature T cells
细胞质和细胞核 THEMIS 在未成熟和成熟 T 细胞中的作用
  • 批准号:
    10331846
  • 财政年份:
    2020
  • 资助金额:
    $ 27.88万
  • 项目类别:
The Role of Cytoplasmic and Nuclear THEMIS in Immature and Mature T cells
细胞质和细胞核 THEMIS 在未成熟和成熟 T 细胞中的作用
  • 批准号:
    9888243
  • 财政年份:
    2020
  • 资助金额:
    $ 27.88万
  • 项目类别:
The Role of Cytoplasmic and Nuclear THEMIS in Immature and Mature T cells
细胞质和细胞核 THEMIS 在未成熟和成熟 T 细胞中的作用
  • 批准号:
    10552636
  • 财政年份:
    2020
  • 资助金额:
    $ 27.88万
  • 项目类别:
Control of the Functional Fate of CD4 T Cells by LncRNA-Switch
LncRNA-Switch 对 CD4 T 细胞功能命运的控制
  • 批准号:
    9170246
  • 财政年份:
    2016
  • 资助金额:
    $ 27.88万
  • 项目类别:
DIFFERENTIATION AND ANTI-VIRAL PROTECTIVE AND PATHOGENIC ROLES OF CD4 CTL
CD4 CTL 的分化、抗病毒保护和致病作用
  • 批准号:
    9246417
  • 财政年份:
    2014
  • 资助金额:
    $ 27.88万
  • 项目类别:
DIFFERENTIATION AND ANTI-VIRAL PROTECTIVE AND PATHOGENIC ROLES OF CD4 CTL
CD4 CTL 的分化、抗病毒保护和致病作用
  • 批准号:
    8655464
  • 财政年份:
    2014
  • 资助金额:
    $ 27.88万
  • 项目类别:
Uncovering the Missing Link that Determines Susceptibility to Autoimmunity
发现决定自身免疫易感性的缺失环节
  • 批准号:
    8518428
  • 财政年份:
    2009
  • 资助金额:
    $ 27.88万
  • 项目类别:
Uncovering the Missing Link that Determines Susceptibility to Autoimmunity
发现决定自身免疫易感性的缺失环节
  • 批准号:
    7846264
  • 财政年份:
    2009
  • 资助金额:
    $ 27.88万
  • 项目类别:
Uncovering the Missing Link that Determines Susceptibility to Autoimmunity
发现决定自身免疫易感性的缺失环节
  • 批准号:
    8134362
  • 财政年份:
    2009
  • 资助金额:
    $ 27.88万
  • 项目类别:
Uncovering the Missing Link that Determines Susceptibility to Autoimmunity
发现决定自身免疫易感性的缺失环节
  • 批准号:
    7939802
  • 财政年份:
    2009
  • 资助金额:
    $ 27.88万
  • 项目类别:

相似海外基金

Development of small molecule inhibitors as anti-inflammatory agents and antidotes for arsenicals
开发作为抗炎剂和砷解毒剂的小分子抑制剂
  • 批准号:
    10727507
  • 财政年份:
    2023
  • 资助金额:
    $ 27.88万
  • 项目类别:
Discovery of New Anti-Inflammatory Agents to Treat COPD
发现治疗慢性阻塞性肺病的新型抗炎药
  • 批准号:
    9194162
  • 财政年份:
    2016
  • 资助金额:
    $ 27.88万
  • 项目类别:
Synthesis of anti-inflammatory agents and their structure-activity relationships studies
抗炎药的合成及其构效关系研究
  • 批准号:
    496858-2016
  • 财政年份:
    2016
  • 资助金额:
    $ 27.88万
  • 项目类别:
    University Undergraduate Student Research Awards
NAAA Inhibitors as Anti-inflammatory Agents, Phase II
NAAA 抑制剂作为抗炎剂,II 期
  • 批准号:
    9201955
  • 财政年份:
    2015
  • 资助金额:
    $ 27.88万
  • 项目类别:
Novel flavonoids as anti-inflammatory agents in alcoholism
新型黄酮类化合物作为酒精中毒的抗炎剂
  • 批准号:
    8251289
  • 财政年份:
    2014
  • 资助金额:
    $ 27.88万
  • 项目类别:
TLR-7 Agonists as Targeted Anti-inflammatory Agents in Arthritis
TLR-7 激动剂作为关节炎的靶向抗炎药
  • 批准号:
    8302750
  • 财政年份:
    2012
  • 资助金额:
    $ 27.88万
  • 项目类别:
Design and in vivo delivery of novel anti-inflammatory agents
新型抗炎剂的设计和体内递送
  • 批准号:
    267940
  • 财政年份:
    2012
  • 资助金额:
    $ 27.88万
  • 项目类别:
    Operating Grants
Development of inlammasome inhibitors to be used as anti-inflammatory agents
开发用作抗炎剂的inlammasome抑制剂
  • 批准号:
    8403458
  • 财政年份:
    2012
  • 资助金额:
    $ 27.88万
  • 项目类别:
TLR-7 Agonists as Targeted Anti-inflammatory Agents in Arthritis
TLR-7 激动剂作为关节炎的靶向抗炎药
  • 批准号:
    8472443
  • 财政年份:
    2012
  • 资助金额:
    $ 27.88万
  • 项目类别:
Development of inlammasome inhibitors to be used as anti-inflammatory agents
开发用作抗炎剂的inlammasome抑制剂
  • 批准号:
    8549297
  • 财政年份:
    2012
  • 资助金额:
    $ 27.88万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了